Insider Transactions in Q1 2021 at Diversicare Healthcare Services, Inc. (DVCR)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2021
|
Ben R Leedle Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+19.9%
|
-
|
|
Mar 16
2021
|
Leslie K. Morgan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+19.9%
|
-
|
|
Mar 16
2021
|
Robert A Mccabe Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+13.14%
|
-
|
|
Mar 16
2021
|
Chad A. Mc Curdy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+7.47%
|
-
|
|
Mar 16
2021
|
Richard M Brame Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+3.65%
|
-
|
|
Mar 16
2021
|
Robert Z Hensley Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+3.77%
|
-
|
|
Mar 16
2021
|
Kerry D. Massey Executive V.P. & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+25.96%
|
-
|
|
Mar 16
2021
|
Rebecca Bodie Executive VP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+36.17%
|
-
|
|
Mar 16
2021
|
James Reed Mc Knight Jr. CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+7.73%
|
-
|
|
Mar 13
2021
|
Ben R Leedle Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15
+0.25%
|
-
|
|
Mar 13
2021
|
Leslie K. Morgan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15
+0.25%
|
-
|
|
Mar 13
2021
|
Robert A Mccabe Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15
+0.13%
|
-
|
|
Mar 13
2021
|
Chad A. Mc Curdy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
57
+0.25%
|
-
|
|
Mar 13
2021
|
Richard M Brame Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19
+0.04%
|
-
|
|
Mar 13
2021
|
Robert Z Hensley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19
+0.04%
|
-
|
|
Mar 13
2021
|
Kerry D. Massey Executive V.P. & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,708
-7.5%
|
$14,124
$3.75 P/Share
|
|
Mar 13
2021
|
Rebecca Bodie Executive VP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,017
-6.23%
|
$3,051
$3.75 P/Share
|
|
Mar 13
2021
|
James Reed Mc Knight Jr. CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,129
-0.93%
|
$30,387
$3.75 P/Share
|
|
Mar 13
2021
|
James Reed Mc Knight Jr. CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,340
+1.81%
|
-
|
|
Jan 11
2021
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
13,502
+2.32%
|
$40,506
$3.85 P/Share
|
|
Jan 08
2021
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
14,318
+2.51%
|
$42,954
$3.62 P/Share
|
|
Jan 07
2021
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,957
+3.83%
|
$92,871
$3.56 P/Share
|
|
Jan 05
2021
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
114,063
+13.25%
|
$342,189
$3.13 P/Share
|
|
Jan 04
2021
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,800
+0.6%
|
$7,600
$2.95 P/Share
|